Scientific Sessions 2025  /  Genomic and Precision Medicine Symposium: Model Systems: Preclinical to Phase I Bridge: Session 3, The Evolving Landscape of Regulation  /  Actualization of the FDA Reauthorization Act 2.0 for genotype-specific cardiovascular therapeutics
Logo

American Heart Association

  23
  0

Final ID:

Actualization of the FDA Reauthorization Act 2.0 for genotype-specific cardiovascular therapeutics

  • Adler, Eric  ( Ucsd , La Jolla , California , United States )
  • Teerlink, John  ( SAN FRANCISCO VAMC UCSF , San Francisco , California , United States )
  • Helms, Adam  ( UNIVERSITY OF MICHIGAN , Ann Arbor , Michigan , United States )
    • Author Disclosures:
    Eric Adler: DO have relevant financial relationships ; Executive Role:Lexeo Therapeutics:Active (exists now) ; Ownership Interest:Papillion Therapeutics:Active (exists now) ; Ownership Interest:Rocket Pharmaceuticals:Active (exists now) | John Teerlink: DO have relevant financial relationships ; Consultant:Amgen:Active (exists now) ; Consultant:LivaNova:Past (completed) ; Consultant:Kaiser Permanente:Active (exists now) ; Consultant:Impulse Dynamics:Active (exists now) ; Consultant:Endotronix:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:EBR Systems, Inc. :Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Cardurion:Active (exists now) ; Consultant:Bristol-Myers Squibb:Active (exists now) ; Consultant:Boehringer-Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Consultant:AskBio:Active (exists now) ; Consultant:Angitia:Active (exists now) | Adam Helms: DO have relevant financial relationships ; Consultant:Lexeo:Active (exists now) ; Consultant:Cytokinetics:Past (completed) ; Consultant:Preload Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Genomic and Precision Medicine Symposium: Model Systems: Preclinical to Phase I Bridge: Session 3, The Evolving Landscape of Regulation

Friday, 11/07/2025 , 04:00PM - 05:15PM

Cardiovascular Seminar

More abstracts on this topic:
Gene editing, replacement, and regulation targeting for cardiomyopathies

Hinson John, Rossano Joseph, Olson Eric, Mcnally Elizabeth

Preclinical development of gene-specific therapeutic strategies for cardiomyopathies

Parikh Victoria, Knollmann Bjorn, Malik Fady

More abstracts from these authors:
Gene Therapy for Lysosomal Storage Disorders: From the Bench to the Bedside

Adler Eric, Greenberg Barry

State of the Art Approaches in Circumventing Hypertrophic Cardiomyopathy in Danon Disease

Adler Eric

You have to be authorized to contact abstract author. Please, Login
Not Available